D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 46.1 CNY -0.17%
Market Cap: 19.2B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dizal Jiangsu Pharmaceutical Co Ltd
Research & Development Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Research & Development
-ÂĄ744.9m
CAGR 3-Years
-22%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Research & Development
-ÂĄ12.5B
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Research & Development
-ÂĄ1.1B
CAGR 3-Years
-54%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Research & Development
-ÂĄ192.9m
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Research & Development
-ÂĄ992.9m
CAGR 3-Years
-41%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Research & Development
-ÂĄ232.4m
CAGR 3-Years
-59%
CAGR 5-Years
-49%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Research & Development?
Research & Development
-744.9m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Research & Development amounts to -744.9m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-31%

Over the last year, the Research & Development growth was -22%. The average annual Research & Development growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been -22% over the past three years , -31% over the past five years .

Back to Top